What is Xogene?
Xogene specializes in clinical trial transparency, merging expert services with advanced technology. The company offers AI-driven platforms designed to streamline compliance and disclosure processes for trial sponsors, thereby boosting both efficiency and accuracy. Xogene's core mission is to transform clinical trial data into easily accessible information, serving over 45 biopharma clients. Their comprehensive offerings include advisory services, medical writing, and data protection solutions, all engineered to simplify the intricate domain of clinical trial transparency and improve patient and caregiver engagement.
How much funding has Xogene raised?
Xogene has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Xogene
PPP
Public-Private Partnership
What's next for Xogene?
With its substantial late-stage funding, Xogene is poised for significant expansion and further innovation in clinical trial transparency solutions. The recent strategic investment signals strong confidence from backers in Xogene's market position and future growth trajectory. This capital infusion will likely fuel the enhancement of their AI-driven platforms, broaden their client base within the biopharma industry, and potentially support the development of new services aimed at further simplifying regulatory compliance and data disclosure. The company's focus on integrating technology with specialized services positions it to lead in making clinical trial data more accessible and manageable.
See full Xogene company page
